Background Antimicrobial resistance (AMR) is a global threat for people with chronic lung infection; however, international ...

Background Pulmonary rehabilitation (PR) is the cornerstone of non-pharmacological treatment for chronic obstructive ...

Macrolide therapy is an established and effective treatment for selected patients with chronic obstructive airways diseases ...

Background: There is a growing recognition that genetic predisposition contributes to the development of fibrotic ...

An 81-year-old woman with a history of diabetes mellitus and angina underwent chest CT after an abnormal chest radiograph ...

A 71-year-old man was admitted with presumed pneumonia. He was previously independent, had never smoked and had no history of ...

1 University of Western Australia, School of Medicine and Pharmacology, Respiratory Medicine Department, Royal Perth Hospital, Western Australia 2 Sir Charles Gairdner Hospital: Western Australian ...

In this report, we detail the results of the 2010 BTS national pleural procedures audit, to which 58 hospitals covering a collective population of more than 20 million patients contributed data ...

7 Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK Correspondence to Dr SC Bourke, North Tyneside General Hospital, Rake Lane, North Shields, Newcastle upon Tyne NE29 8NH ...

Background Previous studies have suggested that long-term use of β agonists to treat chronic obstructive pulmonary disease (COPD) may increase the risk of cardiovascular adverse events. In this post ...

Sarcoidosis of the upper respiratory tract (SURT) includes nasopharyngeal, laryngeal and tracheal disease. Documented SURT occurs in ∼5% of patients, although upper airway symptoms are more common in ...

2 Guy’s, King’s and St Thomas’ School of Medicine, London, UK 3 Department of Psychology, St George’s Hospital Medical School, London, UK 4 Pharmacia Consumer Healthcare, Medical Affairs, Helsingborg, ...